AccurKardia
PrivateLast Round
Seed
Jun 20, 2023
Total Funding Raised
$2.7M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
AccurKardia operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Seed round in June 2023.
AccurKardia is a medical software company that provides an automated, clinical-grade electrocardiogram (ECG) interpretation software platform for cardiac monitoring.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Healthcare Analytics, Telemedicine
Business Model
B2B2C
Customer Profile
Usage-Based SaaS, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AccurKardia Comparables
Compare AccurKardia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cardiomatics | 92% | |
| Idoven | 86% | |
| Powerful Medical | 84% |
For institutional investors. Book with your work email.
AccurKardia Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 24, 2026
Grew 35% QoQ, from 20 to 27 employees.
- Aug 29, 2026
Grew 26% QoQ, from 19 to 24 employees.
For institutional investors. Book with your work email.
AccurKardia Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AccurKardia's valuation, stock price, and market status.
Is AccurKardia a public or private company?
AccurKardia is a private company.
What is the current stock price of AccurKardia?
AccurKardia is a private company, so its shares have no public market price. Caplight tracks AccurKardia's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AccurKardia worth (valuation)?
Valuation information for AccurKardia is not publicly available.
Can I buy AccurKardia stock?
AccurKardia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AccurKardia's last funding round?
AccurKardia's most recent funding round was Seed on June 20, 2023.
Who are the main investors in AccurKardia?
Investor information for AccurKardia is not publicly disclosed.
Will AccurKardia IPO soon?
No public IPO plans have been announced for AccurKardia.
How can I track AccurKardia secondary market activity?
Caplight tracks bids, offers, and trades in AccurKardia's shares on secondary markets.